Examkin

Question

Difficulty: Very hardCardiovascular System

A 28-year-old male is brought to the emergency department due to acute, severe dyspnea and lightheadedness that began one hour ago. The patient has a history of a "heart murmur" diagnosed in childhood and "asthma." He reports developing a mild upper respiratory tract infection three days ago. Over the past 24 hours, he has been using his albuterol metered-dose inhaler every 1 to 2 hours for perceived wheezing and chest tightness. Despite this, his breathing progressively worsened, culminating in a near-syncopal episode just prior to arrival.

Vital signs include a temperature of 37.2°C (99.0°F), blood pressure of 82/50 mm Hg, heart rate of 138/min, and a respiratory rate of 28/min. Pulse oximetry shows an oxygen saturation of 87% on room air.

Physical examination reveals a diaphoretic, pale patient in severe respiratory distress, utilizing accessory muscles of respiration. The jugular venous pressure is estimated at 9 cm H2OH_2O. Palpation of the carotid arteries reveals brisk, bifid upstrokes. Lung auscultation demonstrates diffuse bilateral expiratory wheezes and basilar crackles. Cardiac auscultation reveals a regular tachycardia and a grade 4/6 harsh, crescendo-decrescendo systolic murmur heard best at the left lower sternal border that radiates to the apex but not to the carotids.

An electrocardiogram shows sinus tachycardia, left axis deviation, marked voltage criteria for left ventricular hypertrophy, and deep, narrow Q waves in leads I, aVL, V5, and V6. A portable chest radiograph demonstrates bilateral interstitial infiltrates, prominent pulmonary vasculature, and a normal cardiac silhouette.

Which of the following is the most appropriate initial management for this patient's current condition?

  1. Intravenous phenylephrine and rapid crystalloid infusionAnswer
  2. B
    Intravenous furosemide and noninvasive positive pressure ventilation
  3. C
    Intravenous methylprednisolone and continuous nebulized albuterol
  4. D
    Intravenous dobutamine and norepinephrine
  5. E
    Intravenous nitroprusside and endotracheal intubation

Answer

The most appropriate management is to administer an alpha-1 agonist (such as phenylephrine) and intravenous fluids to increase both afterload and preload, which relieves the dynamic outflow tract obstruction.
The patient's clinical presentation is classic for Hypertrophic Obstructive Cardiomyopathy (HOCM) that has acutely decompensated into cardiogenic shock and pulmonary edema due to excessive albuterol use. Albuterol is a beta-agonist that increases heart rate and myocardial contractility. In HOCM, increased contractility and tachycardia worsen the dynamic left ventricular outflow tract (LVOT) obstruction caused by the systolic anterior motion (SAM) of the anterior mitral valve leaflet. This severe obstruction leads to forward-flow failure (hypotension, lightheadedness) and severe mitral regurgitation, which acutely raises left atrial pressure and causes pulmonary edema (manifesting as crackles and wheezing, often termed 'cardiac asthma'). The definitive initial management for hemodynamic collapse in HOCM is to maximize the size of the left ventricular cavity to relieve the mechanical obstruction. This is achieved by increasing preload (intravenous crystalloid fluids) and increasing afterload without adding positive inotropy (using a pure alpha-1 agonist like phenylephrine).

Step-by-Step Solution

1
Analyze the physical exam and ECG findings to establish the underlying structural cardiac diagnosis.
The brisk, bifid carotid upstrokes (pulsus bisferiens), harsh left lower sternal border systolic murmur, and ECG showing left ventricular hypertrophy with deep, narrow (dagger-like) septal Q waves confirm a diagnosis of Hypertrophic Obstructive Cardiomyopathy (HOCM).
Recognizing the underlying structural heart disease is critical because it fundamentally alters standard resuscitation protocols.
2
Determine the pathophysiology of the patient's acute decompensation.
The patient heavily utilized albuterol (a beta-agonist), which increases heart rate (chronotropy) and myocardial contractility (inotropy). In HOCM, this increases the systolic anterior motion (SAM) of the mitral valve, creating a severe left ventricular outflow tract (LVOT) obstruction and secondary mitral regurgitation. This resulted in elevated left atrial pressure, pulmonary edema, and cardiogenic shock.
Differentiating primary bronchospasm (asthma) from secondary pulmonary venous congestion (cardiac asthma) prevents the administration of fatal contra-indicated medications.
3
Select the pharmacological intervention that reverses the specific hemodynamic derangements of HOCM.
The patient is in hypotensive shock due to dynamic LVOT obstruction. Treatment requires increasing the volume of the left ventricular cavity to separate the septum from the mitral valve leaflet. This is achieved by increasing preload (IV crystalloids) and increasing afterload (phenylephrine, which lacks beta-1 inotropic effects).
Standard shock and heart failure treatments (diuretics, vasodilators, and inotropes) decrease LV cavity size or increase contractility, both of which worsen the obstruction and are strictly contraindicated.

Key Concept

In patients with Hypertrophic Obstructive Cardiomyopathy (HOCM), acute hemodynamic collapse with dynamic LVOT obstruction (often triggered by beta-agonists or volume depletion) must be treated by increasing preload (IV fluids) and increasing afterload (pure alpha-agonists like phenylephrine) while avoiding inotropes, vasodilators, and diuretics.
Estimated Time:2m 0s
Rate this question

Topics

Cardiovascular System

More questions from this topic